All AbMole products are for research use only, cannot be used for human consumption.
BQ-788 is a potent and selective ETB receptor antagonist with an IC50 of 1.2 nM inhibiting ET-1 binding to ETB receptor in human Girrardi heart cells. BQ-788 is an enhancer of AQP4(Aquaporin-4).
| Molecular Weight | 641.8 |
| CAS Number | 173326-37-9 |
| Solubility (25°C) | DMSO 100 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] M A A Arıcı, et al. Effects of BQ-788 on amitriptyline-induced cardiovascular toxicity
[3] Megumu Okada, et al. BQ-788, a selective endothelin ET(B) receptor antagonist
| Related Endothelin Receptor Products |
|---|
| Zibotentan
Zibotentan (ZD4054) is a more selective and specific endothelin-A receptor (ETAR) antagonist with an IC50 value of 21 nM. |
| Ambrisentan
Ambrisentan is an orally active, highly selective antagonist of the endothelin-1 type A receptor. |
| Sitaxsentan sodium
Sitaxsentan (TBC-11251) is an orally active, highly selective antagonist of endothelin A receptors. |
| Macitentan
Macitentan is an orally-active, tissue-targeting dual ET receptor antagonist. |
| Bosentan Hydrate
Bosentan is an endothelin (ET) receptors antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
